Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Talanta|January 22, 2017
Highly selective enrichment of phosphopeptides using Zr4+-immobilized Titania nanoparticlesJunyong Dai, Miaode Wang, Hailong LiuFrontiers in Bioengineering and Biotechnology|April 7, 2023
Laser-activated nanoparticles for ultrasound/photoacoustic imaging-guided prostate cancer treatmentLinkang Xiao, Yunfang Wu, Junyong Dai, et al.International Journal of Molecular Sciences|January 8, 2023
Sonosensitive Phase-Changeable Nanoparticle Mediated Enhanced Chemotherapy in Prostate Cancer by Low-Intensity Focused UltrasoundJunyong Dai, Yunfang Wu, Ziqun Chen, et al.Journal of Visualized Experiments : Jove|April 7, 2025
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal UltrasoundJunyong Dai, Xianli Tang, Teng Zhang, et al.The Analyst|August 25, 2015
Hydrophilic modification of titania nanomaterials as a biofunctional adsorbent for selective enrichment of phosphopeptidesHailong Liu, Tianyi Yang, Junyong Dai, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 11, 2024
A magnetic calcium phosphate for selective capture of multi-phosphopeptidesFangKun Ren, JunYong Dai, JingYi Zhang, et al.Frontiers in Oncology|July 16, 2026
Safety and preliminary efficacy of Disitamab Vedotin combined with Toripalimab and concurrent radiotherapy in bladder-preserving treatment for HER2-positive invasive bladder cancerHan Chen, Nan Liu, Xinyu Chen, et al.Cancer Treatment and Research Communications|April 13, 2021
Efficacy and safety of Prostate stereotactic body radiotherapy for metastatic castration-resistant prostate cancer: A prospective cohort studyJun Li, JunYong Dai, Peng Xian, et al.Cancer Genetics|July 24, 2023
Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancerTeng Zhang, Jun Li, Junyong Dai, et al.BMC Urology|May 26, 2026
Lack of real-world evidence on active surveillance in Chinese patients with prostate cancer: insights from a 10-year cohort and a physician surveyPeng Xian, Pan Li, Gangjun Yuan, et al.Pageof 2